Vimarsana
Biggest News Aggregation in the World

Page 12 - Cell Death News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Death. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Death Today - Breaking & Trending Today

Provital's postbiotic Circanblue revitalises skin's circadian rhythm - Vimarsana News

Provital's postbiotic Circanblue revitalises skin's circadian rhythm

Resetting our lives through our biorhythms – discover the first postbiotic cosmetic active to achieve the resynchronisation of the skin’s circadian cycle after digital overexposure.

39th Health Research Report 16 SEP 2008 – Reconstruction - Vimarsana News

39th Health Research Report 16 SEP 2008 – Reconstruction

Editors Top Five: 1. Substance found in fruits and vegetables reduces likelihood of the flu 2. New study will make criminals sweat 3. Common bronchodilator linked to increased deaths 4. Higher urinary levels of commonly used chemical, BPA, linked with cardiovascular disease, diabetes 5. FDA defends plastic linked with health risks In this issue: 1.…

Novel anti-cancer drug found to sensitize tumor cells to ferroptosis - Vimarsana News

Novel anti-cancer drug found to sensitize tumor cells to ferroptosis

A team of researchers led by Dr. Marcus Conrad from Helmholtz Munich discovered a novel anti-cancer drug, called icFSP1, which sensitizes cancer cells to ferroptosis.

BPGbio Working with US DoD on AI-Based Prostate, Breast Cancer Dx - Vimarsana News

BPGbio Working with US DoD on AI-Based Prostate, Breast Cancer Dx

The company is building off a previous partnership with the agency related to prostate cancer to analyze samples for breast cancer.

Source: 360dx.com
Mutant enzyme 'helps prostate cancer to spread and become more aggressive' - Vimarsana News

Mutant enzyme 'helps prostate cancer to spread and become more aggressive'

Researchers hope the findings might offer new treatment options for aggressive prostate cancer.